Navigation Links
Dalton Pharma Services Announces Successful Completion of Health Canada Inspection

Dalton Announces Successful Completion of Health Canada Inspection and Compliance with European Directive for Manufacture and Testing of Drug Products Imported to the European Union.

Toronto, Ontario (PRWEB) February 1, 2010 -- Dalton Pharma Services, a privately owned Canadian pharmaceutical services provider to leading pharmaceutical companies, today announced successful completion of its recent Health Canada audit. The Company has received a ‘Compliant’ rating following the regulatory agency’s inspection of Dalton’s GMP manufacturing facility.

The Establishment License issued by Health Canada will enable Dalton Pharma Services to continue to manufacture, test and ship sterile commercial products for its existing clients. In addition, Dalton’s solid dose manufacturing suites were also inspected and found to be compliant for formulation, granulation and encapsulation of drug products.

In separate audits by Qualified Persons, Dalton Pharma Services was also found to be compliant with GMP API manufacturing, sterile filling and testing standards for pharmaceutical products in the European Union.

“These successful inspections will allow us to continue to execute on our vision to accelerate drug development for our clients’ pharmaceutical products globally. Dalton’s ability to carry out commercial manufacture of sterile, solid dose pharmaceuticals and API provides integrated drug development and manufacturing solutions. Dalton’s reputation for its ability to complete complex drug manufacturing projects in GMP compliant facilities enhances our clients’ success in bringing the medicines of the future to the market,” said Peter Pekos, President and CEO.

Many of Dalton’s international clients have capitalized on the tremendous advantage of dealing with one CMO from start to finish; from clinical trial manufacturing through to commercial production. Dalton is strategically poised for growth within the EU as the Company adds new commercial pharmaceutical manufacturing relationships.

About Dalton Pharma Services
Dalton Chemical Laboratories Inc. o/a Dalton Pharma Services is a Health Canada approved contract pharmaceutical manufacturer that supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. Dalton provides cGMP manufacturing of solid dosage forms and sterile filling services to its customers at any stage of the regulatory process (Phase I, II, III or commercial). In its state of the art cGMP facilities, Dalton produces active pharmaceutical ingredients at the gram or kilogram scale. Dalton conducts sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilized, under fully validated conditions. In addition, Dalton’s analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

About Dalton Medicinal Chemistry
Dalton Medicinal Chemistry Incorporated (DMC) was established to offer select partners medicinal chemistry capabilities in design and synthesis of new chemical entities.
DMC focuses on quality, creativity and speed in the delivery of innovative, high quality medicinal chemistry capabilities for the identification of new chemical entities which advance our clients' drug discovery programs. Our contributions to clinical development candidate selection include SAR elucidation, design and synthesis of focused compound arrays, hit to lead, lead optimization and generation of intellectual property. DMC has full access to Dalton Pharma Services (DPS) and its world class synthetic laboratories equipped with the latest technology in modern synthetic chemistry, structural determination and purity assessment.

For further information contact:
Peter Pekos
President & CEO
Dalton Pharma Services
Tel: 416-661-2102


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
2. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
3. Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development
4. BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
5. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
6. BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
7. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
8. Onyx Pharmaceuticals Appoints Ted W. Love, M.D., as Head of Research & Development
9. Eribis Pharmaceuticals Receives Investment for Clinical Development of Novel Cardiovascular Therapy
10. Veerman Committee Argues for Continuation of TI Pharma
11. China Yongxin Pharmaceuticals Plans to Open Eighteen New Stores in 2010 to Further Expand Customer Base and Increase Market Share
Post Your Comments:
Related Image:
Dalton Pharma Services Announces Successful Completion of Health Canada Inspection 
(Date:12/1/2015)... December 1, 2015 ... the  "2016 U.K. Virology and Bacteriology Testing ... 100 Tests, Supplier Shares by Test, Innovative ... their offering.  --> ) ... U.K. Virology and Bacteriology Testing Market: Sales ...
(Date:11/30/2015)... ... 30, 2015 , ... Global Stem Cells Group ... the Santiago Marriott. The Global Stem Cells Group GMP facility is equipped with ... qualified medical researchers and practitioners, experienced in administering stem cell protocols using highly ...
(Date:11/30/2015)... , Dec. 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... has joined the American Business Act on Climate Pledge, alongside ... are standing with the Obama Administration to demonstrate an ongoing ... strong outcome to the COP21 Paris ... --> Sarnia, Canada . --> ...
(Date:11/30/2015)... , Nov. 30, 2015 Harvard Apparatus ... a biotechnology company developing bioengineered organ implants for ... notification from The NASDAQ Stock Market that it ... requirements. The letter noted that as a result ... stock having exceeded $1.00 per share for more ...
Breaking Biology Technology:
(Date:11/26/2015)... -- Research and Markets ( ) has announced ... Technology and Patent Infringement Risk Analysis" report to ... --> Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:11/19/2015)... Nov. 19, 2015  Based on its in-depth analysis ... recognizes BIO-key with the 2015 Global Frost & Sullivan ... & Sullivan presents this award to the company that ... the needs of the market it serves. The award ... and expands on customer base demands, the overall impact ...
(Date:11/18/2015)... , Nov. 18, 2015  As new scientific discoveries ... doctors and other healthcare providers face challenges in better ... and patients. In addition, as more children continue to ... patient,s adulthood and old age. John M. ... Children,s Hospital of Philadelphia (CHOP) . --> ...
Breaking Biology News(10 mins):